Skip to content
Screener

Blackrock BLK Contingent consideration fair value adjustment

Contingent consideration fair value adjustment at other companies

Insmed logo
InsmedINSM
-$46.96M-357%
Blackrock logo
BlackrockBLK
$180M+2,100%
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$622K—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$0—

Other financials

Income statement

See full
Revenue$7.1B+30.6%
Operating income$2.5B+42.2%
Net income$1.9B+20.2%
EPS (diluted)$12.19+19.6%

Balance sheet

See full
Cash & equivalents$10.5B+10.7%
Total debt$15.0B+1.8%
Total equity$57.6B+17.2%
Total assets$175.88B+20.1%

Cash flow

See full
Operating cash flow$1.2B-10.0%
CapEx$109.0M+22.5%
Free cash flow$1.1B-12.3%

Valuation

See full
Market cap$175.7B+1.3%
Enterprise value$180.15B+0.8%
P/E26.7×-0.4×
P/S6.4×-1.6×

Profitability

See full
Operating margin32.6%-2.2pp
Net margin24.1%-5.6pp
FCF margin12.9%-5.1pp

Returns & leverage

See full
Return on equity12.3%-2.0pp
Debt / equity0.3×0.0×